These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 6921959)

  • 1. Antagonism of carbenicillin and cefamandole by cefoxitin in treatment of experimental infections in mice.
    Goering RV; Sanders CC; Sanders WE
    Antimicrob Agents Chemother; 1982 Jun; 21(6):963-7. PubMed ID: 6921959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antagonism of cefamandole by cefoxitin in routine disk susceptibility tests.
    Sanders CC; Sanders WE
    Am J Clin Pathol; 1980 Apr; 73(4):562-3. PubMed ID: 7369181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activity of cefamandole, cefoxitin, cefuroxime, and carbenicillin, alone and in combination with aminoglycosides against Serratia marcescens.
    Miller MA; Yousuf M; Griffin PS; Bartlett M; Crane JK
    Microbiol Immunol; 1979; 23(10):955-64. PubMed ID: 390321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro antagonism of beta-lactam antibiotics by cefoxitin.
    Sanders CC; Sanders WE; Goering RV
    Antimicrob Agents Chemother; 1982 Jun; 21(6):968-75. PubMed ID: 6981376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistance to cefamandole: derepression of beta-lactamases by cefoxitin and mutation in Enterobacter cloacae.
    Gootz TD; Sanders CC; Goering RV
    J Infect Dis; 1982 Jul; 146(1):34-42. PubMed ID: 6979593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Piperacillin (T-1220), a new semisynthetic penicillin: in vitro antimicrobial activity comparison with carbenicillin, ticarcillin, ampicillin, cephalothin, cefamandole and cefoxitin.
    Jones RN; Thornsberry C; Barry AL; Fuchs PC; Gavan TL; Gerlach EH
    J Antibiot (Tokyo); 1977 Dec; 30(12):1107-14. PubMed ID: 599084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Susceptibility of cephalothin-resistant gram-negative bacilli to piperacillin, cefuroxime, and other selected antibiotics.
    George WL; Lewis RP; Meyer RD
    Antimicrob Agents Chemother; 1978 Mar; 13(3):484-9. PubMed ID: 122524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emergence of resistance to cefamandole: possible role of cefoxitin-inducible beta-lactamases.
    Sanders CC; Sanders WE
    Antimicrob Agents Chemother; 1979 Jun; 15(6):792-7. PubMed ID: 314270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of correlation between beta-lactamase production and susceptibility to cefamandole or cefoxitin among spontaneous mutants of Enterobacteriaceae.
    Ott JL; Turner JR; Mahoney DF
    Antimicrob Agents Chemother; 1979 Jan; 15(1):14-9. PubMed ID: 311615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiation of resistance determinants to cefamandole and cefoxitin in Enterobacter cloacae strains.
    Vuye A
    Microbios; 1983; 38(153-154):159-69. PubMed ID: 6606106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of intravenous carbenicillin, cefoxitin and cefamandole on ADP-induced platelet aggregation and shape change.
    Fedder IL; Holme S; Vlasses PH; Ferguson RK; Murphy S
    Thromb Res; 1983 Oct; 32(2):215-22. PubMed ID: 6658713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo studies with BL-S786, cefoxitin, and cefamandole.
    Shadomy S; Wagner G; Carver M
    Antimicrob Agents Chemother; 1978 Mar; 13(3):412-5. PubMed ID: 400821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of BL-S786 with cephalothin, cefamandole and cefoxitin in vitro and in treatment of experimental infections in mice.
    Goering RV; Sanders CC; Sanders W
    J Antibiot (Tokyo); 1978 Apr; 31(4):363-72. PubMed ID: 306989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbenicillin plus cefamandole in the treatment of infections in patients with cancer.
    Bodey GP; Ketchel S; Rodriguez V
    J Infect Dis; 1978 May; 137 Suppl():S139-S143. PubMed ID: 649998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of in vitro susceptibility with in vivo efficacy in mice for cefoxitin in comparison with cephalosporins.
    Miller AK; Celozzi E; Pelak BA; Birnbaum J; Stapley EO
    J Antimicrob Chemother; 1979 Sep; 5(5):569-79. PubMed ID: 315403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of clinical pharmacists to reduce cefamandole, cefoxitin, and ticarcillin costs.
    Abramowitz PW; Nold EG; Hatfield SM
    Am J Hosp Pharm; 1982 Jul; 39(7):1176-80. PubMed ID: 7114059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative activity and beta-lactamase stability of cefoperazone, a piperazine cephalosporin.
    Neu HC; Fu KP; Aswapokee N; Aswapokee P; Kung K
    Antimicrob Agents Chemother; 1979 Aug; 16(2):150-7. PubMed ID: 314775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cefamandole and cefoxitin.
    Sanders CV; Greenberg RN; Marier RL
    Ann Intern Med; 1985 Jul; 103(1):70-8. PubMed ID: 3890658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro evaluation of cefoxitin and cefamandole.
    Adams HG; Stilwell GA; Turck M
    Antimicrob Agents Chemother; 1976 Jun; 9(6):1019-24. PubMed ID: 820241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-lactamase stability of cefoxitin in comparison with other beta-lactam compounds.
    Neu HC
    Diagn Microbiol Infect Dis; 1983 Dec; 1(4):313-6. PubMed ID: 6321094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.